Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Some times positive perspective reminders are good ;~)
[{“Instead of being in fear of everything taking a turn for the worst… even if one is feeling they experienced a run of bad luck… some times we have to trust that most of what we fear never happens and just as The Wheel of Fortune turns downwards, it will naturally turn upwards again and bring new good fortune with it. “}]
In my opinion… This difficult phase will pass. Outcomes may well be delayed. However, there is clearly new positive forward moment and action …
it was great to hear in the latest CC that there are lots of interesting and exciting meetings that have been started and continue to be in the works …
We all know anything pharma and fda related takes a seemingly inordinate amount of time to solidify …
I feel that after relistening to the cc not only were many questions answered and explained we now have a take away of knowing MedolifeRx qnta is still working towards escozine goals - the Covid slides and science portion was especially positive and interesting to review.
For those who missed the CC
Here’s the CC link ((fyi passcode to watch / open link is at the bottom of this page ))
Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call
Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
Meeting Recording:
https://us06web.zoom.us/rec/share/bLPZGqeBj6t9ecgZBactMfKt6KOPXZ1Q5qYKn0z5KhawBW_vmc7JFeJNtPhjq0wk.gl8CdDheQtl33mSC
Access Passcode: $uPi^+4r
GLTA MedolifeRx QNTA escozine AELIA
Yes, exactly PennyWorld!! The new shared ceo position makes a lot of sense. imo There was a lot of good information and the slides showing the escozine affect on Covid was particularly explained really well too :)
Covid on the rise where I’m at … thus far I’ve been using the the escozine imunapen since early fall of last year and it’s definitely made a difference
Exactly
I’ll need to relisten and I’ll share once I do
However Dr Mikaelian spoke of a SHARED ceo situation they will now have. I can’t recall the new co-ceo name but the new person will handle all the things your speaking of and dr Mikaelian more the science end If I recall correctly. Heading out right now but I hope to re listen in full over the weekend or early next week ..
ultimately the CC is was talked about and sounded like some very prudent moves being made that will help many aspects move forward with work divided in a way to suit both their strengths
I’m betting the company would be glad to clarify. Part of the entire point of last nights CC was to clear things up with investors concerns and to put forth current events etc. ir@medoliferx.com
I don’t know if they have it transcribed but I would bet they could most certainly clarify :)
Share price currently is indeed frustrating..
however, while extremely frustrating, the past year had many bumps and delays that were unfortunate and unforeseeable….
The run up to 0.20 was on speculation of fda. … as a share holder during that run it was great to witness its potential with news … unfortunately, the fda while accepting all of the data on escozine to that point that they asked of qnta then asked for additional things that prior to Covid vaccines the fda didn’t require … the new tests created huge delays … the RS debacle was crippling as folks panicked based on fears of experienced RS from OTHER companies they assumed similar could happen here…. Packaging delay from gloabal shipping issues slowed the roll out of imunapen and then the high profile NFL & dicks sporting goods events all were canceled due to the national fear of being accused of super spreader events .. mean while all these things discouraged investors…. However, the very noteworthy thing is the company managed to keep moving forward … and in spite of then another blow - the sec investigation… qnta continues to persevere and garner traction on the escozine track…. The last nights cc was incredibly informative and straight forward explaining much in regard to all the questions and concerns on iHub
I’m going to re listen to the cc when I have time to sit with paper and pen to take notes. For those with super busy schedules I suggest playing it while you drive or listen a few times while doing other things… that way if your casually listening you’ll pick up on key things ..
personally I found the information shared to be relevant and forthcoming
Exactly… the CC directly addressed many concerns head on with answers.
Everyone NEEDS to do their own DD
It’s a Fact iHub does NOT monitor nor care if people post fact, fiction, opinion, speculation, lies, or slander…. They said they do not moderate..
ok soooo
Next time you read some one say “I know” or “I think” of types “fact” or even “fraud / scam”…. And they use “intimidating” all caps font in bold colors like red or blue and say “I know” ….
Folks, unless some one posts a link and ir proof to back up their conjecture - anyones motives behind their posts are anyones guess …
I can say this … watch the Cc for yourselves … note, in the CC they address head on MANY of the floated “conjecture” and mis leading info you’ll see on this qnta thread ….
I’ll personally always say things like imo (in my opinion) … and or put a link to a source …
Here’s the CC link again …
I urge any investors and or customers to watch. A lot of information was shared
Dad, fyi Access passcode at bottom of text
Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call
Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
Meeting Recording:
https://us06web.zoom.us/rec/share/bLPZGqeBj6t9ecgZBactMfKt6KOPXZ1Q5qYKn0z5KhawBW_vmc7JFeJNtPhjq0wk.gl8CdDheQtl33mSC
Access Passcode: $uPi^+4r
Ps it’s beautiful outside today. I hope if it’s good weather wherever your reading this you get a chance to go outside:)
Here’s the CC link ((fyi passcode to watch / open link is at the bottom of this page ))
Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call
Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
Meeting Recording:
https://us06web.zoom.us/rec/share/bLPZGqeBj6t9ecgZBactMfKt6KOPXZ1Q5qYKn0z5KhawBW_vmc7JFeJNtPhjq0wk.gl8CdDheQtl33mSC
Access Passcode: $uPi^+4r
Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call
Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
Meeting Recording:
https://us06web.zoom.us/rec/share/bLPZGqeBj6t9ecgZBactMfKt6KOPXZ1Q5qYKn0z5KhawBW_vmc7JFeJNtPhjq0wk.gl8CdDheQtl33mSC
Access Passcode: $uPi^+4r
The CC last night was indeed very informative and much time was taken to dispel many false claims that have been floating around … they answered many questions.. also lots good shared information on forward looking things too
Quote from qnta that was posted along with the CC sign up alerting folks it will be recorded
“For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.”
You can sign up at their investor page for emails and you’ll receive info directly
Or just check in on their page for postings
At
https://ir.quantrx.com/
As soon as a link to cc is made available I’ll gladly share it.
Meanwhile, here’s an older CC to show that the CC are and have been recorded in the past as well
https://vimeo.com/580475668
{**also worth noting .. at About the 25:00 minute mark, listen & watch closely - great slides / data re covid **}
https://vimeo.com/580475668
“For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.”
^^^^^^^ that is a quote / excerpt from the information that was shared on qnta investor page along with info on how to have been able to join last nights cc
Link to QNTA investor page below
….
The CC was last night at 5pm eastern
I posted the information several times on how to log in / sign up for and where to submit questions to before hand in order to get them answered over the cc. The cc was last night and was very informative. I share the recorded link as soon as it’s posted publicly on the qnta ir page. Also here was the info about the conference call. Note .. it states a recorded version will be made available to those who missed it …
https://ir.quantrx.com/
https://ir.quantrx.com/news-events/press-releases/detail/101/medolife-rx-schedules-conference-call-with-investment
“The Company will answer as many questions as time will allow. For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.”
I felt things were answered … did you get a chance to listen in last night? The conference call addressed a plethora of questions brought forth by investors…
Once link to last nights cc is available if some one doesn’t post I’ll be sure to share it.
Takes a few days .. but the link to the cc should eventually be posted here at the following investor relations page :
https://ir.quantrx.com/
They said link will be available… as it was recorded. Lots of things discussed
Once I get link I’ll post.. unless some one beats me to it :)
Science [{“The chemistry of different venoms may also provide a tool to combat cancer directly. Venom peptides, which are short chains of amino acids, manipulate cellular signals by targeting specific receptors. That means some venom components may be able to turn off tumor cell production while leaving healthy cells alone.”}]
The Above and below
are Excerpts from the following article…
It’s fascinating researching about all the various venoms and pharma …
https://www.nationalgeographic.com/science/article/how-harnessing-the-powers-of-venom-could-lead-to-new-medicines?cmpid=int_org=ngp::int_mc=website::int_src=ngp::int_cmp=amp::int_add=amp_readtherest
[{“In the United Kingdom, Carol Trim, a senior lecturer at Christchurch University, and her Ph.D. student Danielle McCullough have been investigating a protein found in certain cancer cells called the epidermal growth factor receptor, and how venoms from snakes, scorpions, and tarantulas can block this receptor’s activity. In New York, Holford is working on characterizing snail venom peptides with the goal of developing new therapies for cancer and pain management.”}]
Interesting read “The bite that cures: how we’re turning venom into medicine”
https://www.sciencefocus.com/nature/the-bite-that-cures-how-were-turning-venom-into-medicine/amp/
[{. “You can’t get much more exotic than venomous animals and that’s where scientists are turning their attention. Venoms are cocktails made up of between tens and hundreds of different toxins, usually proteins and smaller chains of amino acids similar to proteins called peptides, “
“It’s evolution that’s made venom such a good source of drugs, says Dr Zoltan Takacs, a Hungarian-born scientist-adventurer who founded the World Toxin Bank. “Venom toxins are among the most potent and precision-targeted molecules on Earth,”
Scorpion TARGETS: Cancer, muscular dystrophy, chronic pain, erectile dysfunction
Scorpion venom could be medically useful as a way of marking up brain tumour cells for surgery, as it’s tough for surgeons to identify where a tumour ends and healthy cells begin. If they err on the side of caution, cancer cells get left behind. If they get too knife-happy, then healthy cells are cut out alongside cancer. Chlorotoxin, a component of venom from the cheerily named deathstalker scorpion, binds to tumour cells. Adding a fluorescent tag means that tumours ‘light up’, allowing a surgeon to clearly see their boundaries. This ‘tumour paint’, developed by researchers at the Fred Hutchinson Cancer Research Center in the US, has been tested in animals and is now being trialled in people.”}]
Reminder QNTA conference call TODAY
Thurs, May12, 2022 05:00 PM Eastern Time
*** On the webcast, Medolife CEO Dr. Arthur Mikaelian will discuss the Company’s recently achieved milestones, as well as the future positioning of the Company ***
To register for this call, please use the below web link:
https://us06web.zoom.us/webinar/register/WN_oPsR6XT3QOyuze3yp-eZyQ
QNTA MedilifeRx AELIA escozine
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
Submit questions TODAY by NOON eastern standard time - particulars and links below For the CC scheduled 5/12/22
QNTA conference call with investors for Thursday, May 12
To register for this call, please use the below web link:
https://us06web.zoom.us/webinar/register/WN_oPsR6XT3QOyuze3yp-eZyQ
If you have questions,
please send an email to ir@medoliferx.com
with ‘QNTA Question’ in the subject line
by NOON Eastern Daylight Time
on Wednesday, May 11.
The Company will answer as many questions as time will allow. For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.
https://ir.stockpr.com/buyquanta/sec-filings-email/content/0001493152-22-011986/ex99-1.htm
CC reminder
5/12/22 conference call info below :
QNTA announced today that it has scheduled a conference call with investors for Thursday, May 12
To register for this call, please use the below web link:
https://us06web.zoom.us/webinar/register/WN_oPsR6XT3QOyuze3yp-eZyQ
If you have questions,
please send an email to ir@medoliferx.com
with ‘QNTA Question’ in the subject line
by NOON Eastern Daylight Time
on Wednesday, May 11.
The Company will answer as many questions as time will allow. For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.
https://ir.stockpr.com/buyquanta/sec-filings-email/content/0001493152-22-011986/ex99-1.htm
“We will see an explosion of information about venoms and venomous animals in the next 10 years or so.“
—Glenn King
Sooooo many good things in the pipelines for venom pharmaceuticals… in our lifetime we are so fortunate we will get to see many advancements in this sector …
… MedolifeRx, in my opinion, is poised with all the potential to be among those in the forefront of the venom candidates …
Interesting read :
https://www.pnas.org/doi/10.1073/pnas.2004486117
“Venom back in vogue as a wellspring for drug candidates
How a new wave of research on venoms from an array of creatures could seed future pharma development.”
================================
***also : CC sign up REMINDER***
QNTA announced that it has scheduled a conference call with investors for Thursday, May 12
To register for this call, please use the below web link:
https://us06web.zoom.us/webinar/register/WN_oPsR6XT3QOyuze3yp-eZyQ
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
If you have questions, please send an email to ir@medoliferx.com
with ‘QNTA Question’ in the subject line
by NOON Eastern Daylight Time on Wednesday, May 11.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
The Company will answer as many questions as time will allow. For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.
*************************************************
https://ir.stockpr.com/buyquanta/sec-filings-email/content/0001493152-22-011986/ex99-1.htm
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
QNTA MedolifeRx AELIA escozine
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
https://aeliastore.com/
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
FYI
Here’s the quote in Apr 6, 2021 pr where PRODUCT purchase order was mentioned …
———-
Apr. 6, 2021 8:30 AM ET
“The purchase order for 1,400 Immunapen™ Originals came from a pharmaceutical wholesaler based in the Republic of Armenia “
https://www.newmediawire.com/news/medolife-rx-receives-significant-purchase-order-of-immunapen-its-easy-to-use-nutraceutical-product-designed-to-increase-quality-of-life-and-support-a-healthy-immune-system-5227874
I copy and pasted & emailed your questions verbatim …
~~~~~
Just a note in the meantime:
In the 2021 10k The information about the $ is there; The $2 million was in valuation in shares and was compensation when the merger occurred and patent comp
.. his salary is actually $88k
~~~~~~
But nonetheless I sent the entire list of questions just now :)
Have a great evening everyone
“An important mechanism of action of the peptide is that it binds only to cancer cells, leaving healthy cells untouched. The peptide in Escozine® “
… the Avenue of “Covid” is to assist fast track escozine.. once the ingredient gets approved it’s easier to get cancer avenues through …
https://www.biospace.com/article/releases/medolife-rx-announces-successful-stability-results-on-escozine-conjugated-with-radioactive-iodine/
Your story is a testimony of strength … I have friends who have fled various countries under various circumstances … we are very lucky if we didn’t have to endure such hardships… Vietnam, Iraq, Iran, and Ethiopia to name a few. Each story unique and heart wrenching … thank you for sharing your story
Btw, I agree with you on ivermectin, I’ve been using the escozine immunipen twice daily, then when Knowingly exposed to positive Covid take ivermectin preemptively (before I have symptoms myself) and have side stepped Covid thus far … example, we were traveling recently this month … 1/2 the people we traveled with returned to their homes after the week and tested positive for Covid … a few of them got a really bad version of it … my house hold has been proactively boosting our immune system and we avoided it.
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
Umm you said “COVID IS OVER and done”
Hardly … unfortunately it’s not .. “After months of declining numbers, California has recorded a nearly 30% increase in coronavirus cases over the last week along with smaller rises in hospitalizations, causing some health officials to suspect that the state is headed into a new pandemic wave.” https://www.latimes.com/california/story/2022-05-02/here-we-go-again-california-coronavirus-cases-up-hospitalizations-begin-to-rise?_amp=true
Also .. Covid therapeutic is a pathway for getting fda approved faster than cancer pathway …
Cancer drug is the ultimate objective and data sets thus far show great results
“important mechanism of action of the peptide is that it binds only to cancer cells, leaving healthy cells untouched. The peptide in Escozine” https://www.biospace.com/article/releases/medolife-rx-announces-successful-stability-results-on-escozine-conjugated-with-radioactive-iodine/
FYI folks ca Sign Up For Email Alerts
and Receive updates straight into your inbox directly from QNTA when news is published :
https://ir.quantrx.com/news-events/email-alerts
Information above was found at :
https://ir.quantrx.com/
Found the information from a prior post
….
It was indeed PRODUCT not the company and it was disclosed April 6, 2021
…
FARMATSEVTIK is a brand new company in Armenia … FARMATSEVTIK is its own separate entity …
March 2021 there was a purchase order for 1,400 units of immunipen
the sale was disclosed April 6 2021 in a press release under * related party transactions $198,800.
….
**** Ill suggest again, any investors having questions, submit them as suggested by QNTA before may 11.. also I suggest signing up for the conference call … details in the below link …
https://ir.quantrx.com/news-events/press-releases/detail/101/medolife-rx-schedules-conference-call-with-investment
PennyWorld: you suggested {“ Someone should record the call”}
Good question, I’ve actually posted links to prior CC when they’ve been made available… just like this one will be made available too -
read From QNTA:
{{“For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.”}}
As noted in todays ir news
Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions
https://ir.quantrx.com/news-events/press-releases/detail/101/medolife-rx-schedules-conference-call-with-investment
Shoondale : you posted ; “When I have more time later today or tomorrow I'll post some issues that should be addressed.instead of just the cherry picked questions. “
I’ll share the following again for all others to see too in case they missed - QNTA put out publicly this morning to submit questions to:
[{{{ “If you have questions, please send an email to ir@medoliferx.com with ‘QNTA Question’ in the subject line by NOON Eastern Daylight Time on Wednesday, May 11”. }}}}]
Link to todays QNTA press release:
https://ir.quantrx.com/news-events/press-releases/detail/101/medolife-rx-schedules-conference-call-with-investment
It was immunipens… I put all the details out a few days ago … I’m not near my notes but I’ll look later and get back to you
5/12/22 conference call info below :
QNTA announced today that it has scheduled a conference call with investors for Thursday, May 12
To register for this call, please use the below web link: https://us06web.zoom.us/webinar/register/WN_oPsR6XT3QOyuze3yp-eZyQ
If you have questions, please send an email to ir@medoliferx.com with ‘QNTA Question’ in the subject line by NOON Eastern Daylight Time on Wednesday, May 11. The Company will answer as many questions as time will allow. For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.
https://ir.stockpr.com/buyquanta/sec-filings-email/content/0001493152-22-011986/ex99-1.htm
Conference Call Topics:
? Potential investment infusion;
? Further developments on FDA Pre-IND application #150335 for Escozine as a COVID-19 treatment;
? Lobbying to the FDA;
? Update on Dominican Republic controlled double-blind clinical strategy for Escozine as a COVID-19 treatment;
? Mexico importation and distribution of Escozine, and clinical strategy and preparation for a study on Escozine as a COVID-19 treatment;
? The Company’s name and stock symbol change status;
? Changes to the Company’s executive management and corporate control;
? Additional distribution opportunities;
? Implementation of new sales and marketing strategies;
? Collaborative opportunities with large pharmaceutical companies;
? Change in the Company’s independent auditing firm;
? Addressing recent concerns from shareholders;
PR : Thursday May 12, 2022 5:00pm CC
To register for this call, please use the below web link: https://us06web.zoom.us/webinar/register/WN_oPsR6XT3QOyuze3yp-eZyQ
In short … i think it’s the sec situation that stalled many things …
Hi PB!! They have been working on getting better response times to investors
I have had several questions answered recently - and at which time they expressed since many have questions they plan to have a CC soon … in the mean time they’ve asked if folks want to email questions to do so in order for CC to be as comprehensive as possible
Send them your thoughts - they are looking forward to hearing from iHub investors at
ir@medoliferx.com
ir@medoliferx.com when I email I get replies, questions get answers …
I’ve also spoke with them on the phone
… REAL product ships to my house monthly that I and my family uses
https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/
ir@medoliferx.com I suggest Reach out to qnta directly … I’ve had both email and phone contact … a company won’t set and push a pr date for a conference call until they have the information and date set and ready. In the mean time I encourage all investors to reach out via email, include your name and phone number and questions / concerns etc.
ir@medoliferx.com
I know for a fact I am not the only one who has had contact with them.
ir@medoliferx.com
Actually, with almost 5,000,000 shares traded today it’s about $31,000.
SP is up for the day
… good no matter how you slice it …
obviously, as investors, seeing the SP go up is good … beats the alternative
let’s hope this is a continued trend
There’s no PR on the conference call yet because they haven’t set a date and time I think everyone needs to have a little patience sending their questions and then they gather all the data and have things to say in reply they will set a date and time historically they have had conference calls that lasted for well over an hour each and every time and within each conference call they took the time to field questions that were sent yet
I agree with you …
Worth noting though is anything to do with the FDA and the pharmaceutical realm as everybody on this board knows full well takes years if not decades to reach the pinnacle …
like I mentioned numerous times
the products are good they work as described
now let’s just wait and see what they have to say and present to us in the conference call and see how things are progressing
ir@medoliferx.com